Tudor Investment Corp
CYCN icon

Tudor Investment Corp’s Cyclerion Therapeutics CYCN Stock Holding History

Tudor Investment Corp’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-903
Closed -$49K – 1109
2019
Q4 		$49K Sell
903
-577
-39% -$53.9K ﹤0.01% 1088
2019
Q3 		$359K Buy
1,480
+28
+2% +$6.05K 0.01% 805
2019
Q2 		$333K Buy
+1,452
New +$411K 0.01% 830

Other funds holding CYCN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Tudor Investment Corp's CYCN Position: Q1 2020 in Review

Tudor Investment Corp sold out of Cyclerion Therapeutics (CYCN) in Q1 2020, closing a stake of 903 shares — an estimated $49K sold.

Tudor Investment Corp first reported a position in CYCN in Q2 2019 and held it in 3 quarters. The position peaked at $359K in Q3 2019. 80 funds tracked by Wall St. Rank hold CYCN as of Q1 2020.

  • Tudor Investment Corp reported no remaining Cyclerion Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Tudor Investment Corp sold 903 Cyclerion Therapeutics shares in Q1 2020, an estimated $49K.
  • Tudor Investment Corp first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 3 quarters.
  • Tudor Investment Corp's Cyclerion Therapeutics position peaked at $359K in Q3 2019.
  • 80 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q1 2020.

Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.